Latest round

Series A

Last raised

Dec 2024

Total raised

$12M

Investors

9

About DeepLife

Based in France, DeepLife SAS DeepLife is a biotechnology company specializing in leveraging artificial intelligence and multi-omics data to model cellular behaviors and engineer cellular systems. The company was founded by Jonathan Baptista (CEO), and Jean-Baptiste Morlot. DeepLife offers a suite of products designed to facilitate drug discovery and cellular research. Their primary offerings include DeepLife Datastore™ which is a comprehensive multi-omics database providing access to harmonized datasets from over 30 qualified data repositories. Additionally, it provides DeepLife Analysis™ tools for analyzing and interpreting complex biological data as well as DeepLife Virtual Cell™ which is a simulation platform that creates digital twins of cells to explore and manipulate their behavior in silico.

Who invested in DeepLife

9 investors across 2 rounds

See all investors in DeepLife

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 11, 2024

    Amount

    $10M

    Investors

    Locked

  2. Seed

    Sep 22, 2022

    Amount

    $1.8M

    Investors

    Locked

Questions about DeepLife

Who invested in DeepLife?

DeepLife has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has DeepLife raised?

DeepLife has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did DeepLife last raise money?

DeepLife's most recent round on record is a Series A, in Dec 2024.

What does DeepLife do?

Based in France, DeepLife SAS DeepLife is a biotechnology company specializing in leveraging artificial intelligence and multi-omics data to model cellular behaviors and engineer cellular systems.

Where is DeepLife headquartered?

DeepLife is headquartered in France.

Which VCs invest in companies like DeepLife?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at DeepLife's stage. Their profiles are linked below.

Raising like DeepLife? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.